School of Medicine
Showing 61-80 of 89 Results
-
Chad Anderson
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioChad Anderson is a Physician Assistant at Stanford ValleyCare and a Clinical Assistant Professor with the Stanford School of Medicine MSPA program. He is the Assistant Director of PA education at ValleyCare. He is dual credentialed as a Family Nurse Practitioner and a Physician Assistant. He completed his FNP/PA training at the Stanford School of Medicine and his graduate studies at A.T. Still University – Arizona School of Health Sciences. He is passionate about improving our patients hospital experience as well as educating our future providers.
-
Jason Andrews
Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemology
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Justin P. Annes M.D., Ph.D.
Associate Professor of Medicine (Endocrinology)
On Partial Leave from 05/01/2024 To 02/28/2025Current Research and Scholarly InterestsThe ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders
DIABETES
The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.
(1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.
(2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.
HEREDIATY PARAGAGLIOMA SYNDROME
The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.
As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families. -
Sally Arai
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsResearch interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.
-
Danit Ariel
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDanit Ariel, MD MS, is board certified in Endocrinology. Dr. Ariel graduated from UC Davis School of Medicine. She then completed a residency in Internal Medicine at Stanford and a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty at Stanford.
Dr. Ariel practices general endocrinology, with a special interest in menopause, LGBTQ+ health, transgender medicine, reproductive endocrinology and thyroid disorders amongst others.
She believes in practicing compassionate care: in listening to her patients’ concerns, respecting their values, communicating well, and providing an evidence-based approach to help guide individualized treatment plans. She is deeply committed to utilizing her expertise in the field of endocrinology to optimize her patients’ health and well-being.
Dr. Ariel is passionate about medical education and teaching, and serves on the teaching faculty in the Stanford University School of Medicine. She completed an honors certificate in medical education from Stanford. She is the Founding Director of the Student Guidance Program for medical students. Finally, within the division of Endocrinology, she is the Director of Faculty Wellness.
Appointments with with Dr. Ariel are available in the Hoover Pavilion on 211 Quarry Road as part of the Stanford Health Care Endocrinology Clinic and the Stanford Health Care LGBTQ+ Health Program. -
Julia Anne Armendariz
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioI have a passion for medical education and underserved patient communities, so my job at the Palo Alto VA suits me perfectly. I have the joy of being a course director for the Stanford Internal Medicine Medical Education Elective (along with Drs. Sharmin Shekarchian and Poonam Hosamani), which is one of my very favorite things in life. The best things about being a doctor are learning new things each day, bearing witness to the human experience of illness, and taking part in relieving suffering and promoting health within my community. My hobbies include anything outdoors, working in my garden, and baking up delicious treats.
-
Lucia Aronica
Casual - Non-Exempt, Medicine - Med/Stanford Prevention Research Center
BioFor over fifteen years, my research has focused on epigenetics - how environmental factors can influence gene activity and health outcomes. Unlike fixed genetics, epigenetic modifications are flexible and can store cellular memories from diet, stress, toxins, etc. This offers exciting potential for personalized health, as epigenetic markers can reveal susceptibility for exposure-driven diseases like obesity, diabetes, cardiovascular disease, and cancer.
I currently lead epigenetic analysis for the DIETFITS study by Dr. Christopher Gardner, the largest trial ever on low carb versus low fat diets for weight loss. My goal is to understand how weight loss alters gene activity through epigenetic changes, and whether these biomarkers can guide personalized diet strategies.
I also teach Nutritional Genomics at Stanford Continuing Studies, Stanford Sports Medicine, and the Stanford Center for Professional Development. As an award-winning science communicator, I use innovative formats like digital drawings to explain complex epigenetics concepts.
Additionally, I serve as an advisor to personal genomics companies, self-tracking technology startups, and investors in precision health research. I am passionate about translating epigenetics into practical lifestyle advice to optimize wellbeing. -
Anna Chen Arroyo
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Arroyo specializes in the treatment of allergic conditions including drug allergy and asthma. She has a special interest in understanding health and healthcare disparities in allergic diseases and how allergies change over a person's lifetime.
-
Maja Artandi, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Artandi is a Professor of Medicine in the Division of Primary Care and Population Health at Stanford. She is a leader in Primary Care, spearheading novel methods of health care delivery and education. She offers an impressive clinical background and has received several educational and leadership awards.
Her expertise lies in the development and implementation of a medical curriculum focused on the patient-physician interaction, emphasizing communication skills, physical examination skills and medical decision making to support best clinical practices.
Dr. Artandi is a dedicated Primary Care physician and educator and has served as a mentor for many students, residents and colleagues. She is currently the mentorship lead for the Division of Primary Care and Population Health.
She is in the process of getting an executive coaching certification and is faculty for the Advancing Communication Excellence at Stanford Program with the goal of helping her colleagues improve their communication skills.
From 2013-2021 she was the Co-Director of Primary Care education for the Stanford Internal Medicine residency program and co-founded and co-directed the Primary Care program (ACE) within the Stanford Internal Medicine Residency program.
Dr. Artandi is currently the Co-President of the Society of Bedside Medicine, an international society dedicated to studying and improving the patient/physician interaction.
She is a fellow of the Royal College of Physicians Edinburgh and of the American College of Physicians and currently serves as the Wellness chair for the Northern California ACP chapter. -
Steven Artandi, MD, PhD
Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
